Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Plos One|March 6, 2020
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSFSylvain Garciaz, Patrick Sfumato, Angela Granata, et al.
Experimental Hematology|October 2, 2012
Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experienceJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Bulletin Du Cancer|November 16, 2016
[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)]Stéphanie Nguyen, Yves Chalandon, Claude Lemarie, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant CyclophosphamideAnne Wanquet, Stephania Bramanti, Samia Harbi, et al.
Leukemia & Lymphoma|February 18, 2016
The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemiaAnne Wanquet, Roberto Crocchiolo, Sabine Furst, et al.
Hematology/Oncology and Stem Cell Therapy|April 5, 2011
Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myelomaJean El Cheikh, Elias Kfoury, Boris Calmels, et al.
American Journal of Hematology|March 6, 2013
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Bone Marrow Transplantation|November 8, 2018
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patientsThomas Pagliardini, Samia Harbi, Sabine Fürst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in childrenVincent Barlogis, Laurence Glasman, Corine Brunet, et al.
Experimental Hematology|March 27, 2012
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Pageof 4